Exact Mass: 449.1733

Exact Mass Matches: 449.1733

Found 58 metabolites which its exact mass value is equals to given mass value 449.1733, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Glisoxepide

N-{2-[4-({[(azepan-1-yl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-5-methyl-1,2-oxazole-3-carboxamide

C20H27N5O5S (449.1733)


Glisoxepide is one of the sulphonamide-derived oral antidiabetic drugs. It inhibits the uptake of bile acids into isolated rat hepatocytes. However it inhibits taurocholate uptake only in the absence of sodium ions. Glisoxepide uptake could be further inhibited by blockers of the hepatocellular monocarboxylate transporter, by the loop diuretic bumetanide, by 4,4-diisothiocyano-2,2-stilbenedisulfonate (DIDS) and by sulphate. These results are consistent with the transport of glisoxepide via the transport system for the unconjugated bile acid cholate. (PMID:1618280, 9017793). A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

   
   
   
   
   
   
   
   

Ala Ala Cys Trp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5S (449.1733)


   

Ala Ala Trp Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C20H27N5O5S (449.1733)


   

Ala Cys Ala Trp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5S (449.1733)


   

Ala Cys Trp Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C20H27N5O5S (449.1733)


   

Ala Trp Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-sulfanylpropanoic acid

C20H27N5O5S (449.1733)


   

Ala Trp Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]propanoic acid

C20H27N5O5S (449.1733)


   

Cys Ala Ala Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5S (449.1733)


   

Cys Ala Trp Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C20H27N5O5S (449.1733)


   

Cys Trp Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]propanamido]propanoic acid

C20H27N5O5S (449.1733)


   

Gly Gly Met Trp

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5S (449.1733)


   

Gly Gly Trp Met

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C20H27N5O5S (449.1733)


   

Gly Met Gly Trp

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5S (449.1733)


   

Gly Met Trp Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C20H27N5O5S (449.1733)


   

Gly Trp Gly Met

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C20H27N5O5S (449.1733)


   

Gly Trp Met Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]acetic acid

C20H27N5O5S (449.1733)


   
   
   
   
   
   

Met Gly Gly Trp

(2S)-2-(2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}acetamido)-3-(1H-indol-3-yl)propanoic acid

C20H27N5O5S (449.1733)


   

Met Gly Trp Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]acetic acid

C20H27N5O5S (449.1733)


   
   

Met Trp Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]acetamido}acetic acid

C20H27N5O5S (449.1733)


   
   
   
   
   
   
   

Trp Ala Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]propanamido]-3-sulfanylpropanoic acid

C20H27N5O5S (449.1733)


   

Trp Ala Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]-3-sulfanylpropanamido]propanoic acid

C20H27N5O5S (449.1733)


   

Trp Cys Ala Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]propanamido]propanoic acid

C20H27N5O5S (449.1733)


   

Trp Gly Gly Met

(2S)-2-(2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}acetamido)-4-(methylsulfanyl)butanoic acid

C20H27N5O5S (449.1733)


   

Trp Gly Met Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-4-(methylsulfanyl)butanamido]acetic acid

C20H27N5O5S (449.1733)


   

Trp Met Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]acetamido}acetic acid

C20H27N5O5S (449.1733)


   

Glisoxepid

N-{2-[4-({[(azepan-1-yl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-5-methyl-1,2-oxazole-3-carboxamide

C20H27N5O5S (449.1733)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

   

Coelenterazine e

Coelenterazine e

C28H23N3O3 (449.1739)